SBRT shows tolerability in high-risk and recurrent prostate cancer
Presentation at the 2024 Radiosurgery Society (RSS) Meeting in Chicago, Illinois.
https://www.urologytimes.com/view/sbrt-shows-tolerability-in-high-risk-and-recurrent-prostate-cancer
Interested in more discussions like this? Go to the Prostate Cancer Support Group.